Institut National de la Santé Et de la Recherche Médicale, France
inserm.frLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
372
Active
102
Phase 3
14
Total enrollment
790,239
Pipeline matrix
Showing 17 of 17 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Lidocaine 20mg/ml | — | — | — | — | — | 1 | |
| Levobupivacaine Hydrochloride 1.25 MG/ML | — | — | — | — | — | 1 | |
| Sodium Chloride 0.9% Inj | — | — | — | — | — | 1 | |
| salivary collections of amylase and cortisol | — | — | — | — | — | 1 | |
| COL7A1-SIN retroviral vector engineered autologous tissue-engineered skin | — | — | — | — | — | 1 | |
| LBT-999 | — | — | — | — | — | 1 | |
| Favipiravir | — | — | — | — | 3 | ||
| Blood sampling | — | — | — | — | — | 2 | |
| genetic restrospective study | — | — | — | — | — | 1 | |
| Lumbar puncture | — | — | — | — | — | 1 | |
| Blood sample collection; gastrointestinal biopsy | — | — | — | — | — | 1 | |
| blood draw | — | — | — | — | — | 1 | |
| Collection of samples | — | — | — | — | — | 1 | |
| Belatacept Injection [Nulojix] | — | — | — | — | — | 1 | |
| DNA from subjects will be stored in the biobank of our study. | — | — | — | — | — | 1 | |
| blood sample | — | — | — | — | — | 1 | |
| Collection of a salivary sample | — | — | — | — | — | 1 |
Next readouts
- 2022-02-19
- 2024-10-04
- 2025-05-14
- 2026-08-12
- 2026-09-08
- 2027-01-07
- 2027-03-25
- 2027-06
- 2027-06-09
- 2027-09
Top conditions
- Healthy11
- Parkinson's Disease11
- Parkinson Disease9
- Stroke9
- Huntington Disease7
- Influenza5
- Multiple Sclerosis5
- Obesity5
Frequently asked questions about Institut National de la Santé Et de la Recherche Médicale, France
- How many clinical trials does Institut National de la Santé Et de la Recherche Médicale, France have on ClinicalTrials.gov?
- Institut National de la Santé Et de la Recherche Médicale, France is listed as the lead sponsor on 372 clinical trials in ClinicalTrials.gov, 102 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Institut National de la Santé Et de la Recherche Médicale, France's trials are in Phase 3?
- 14 of Institut National de la Santé Et de la Recherche Médicale, France's trials are in Phase 3, spread across 17 active drug programs.
- What therapeutic areas does Institut National de la Santé Et de la Recherche Médicale, France focus on?
- Institut National de la Santé Et de la Recherche Médicale, France's most-studied conditions on ClinicalTrials.gov are Healthy, Parkinson's Disease, Parkinson Disease, Stroke, Huntington Disease.
- When are Institut National de la Santé Et de la Recherche Médicale, France's next clinical trial readouts?
- Institut National de la Santé Et de la Recherche Médicale, France has 10 upcoming primary-completion readouts tracked here; the soonest is “Population Genomic Diversity of France”, expected around 2022-02-19.